Your browser doesn't support javascript.
loading
Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.
Wang, Yang; Liu, Yanna; Liao, Hao; Deng, Zhongping; Bian, Dandan; Ren, Yan; Yu, Guangxin; Jiang, Yingying; Bai, Li; Liu, Shuang; Liu, Mei; Zhou, Li; Chen, Yu; Chen, Xinyue; Duan, Zhongping; Lu, Fengmin; Zheng, Sujun.
Afiliação
  • Wang Y; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Liu Y; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Liao H; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
  • Deng Z; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
  • Bian D; Department of Clinical Laboratory, Shenzhen Third People's Hospital, Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases, Shenzhen, 518112, PR China.
  • Ren Y; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
  • Yu G; Hunan Provincial Key Laboratory of Gene Diagnostic Technology, Changsha 410205, China.
  • Jiang Y; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Bai L; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Liu S; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Liu M; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Zhou L; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
  • Chen Y; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Chen X; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Duan Z; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Lu F; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Zheng S; Liver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Int J Med Sci ; 19(5): 858-866, 2022.
Article em En | MEDLINE | ID: mdl-35693741
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Idioma: En Revista: Int J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Hepatite B Crônica / Antígenos de Superfície da Hepatite B Idioma: En Revista: Int J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China